Stoke Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Bedford, MA
STOK chart
What traders are saying about $STOK
Latest postsStoke Therapeutics, Inc. news
- Epilepsy Market Set to Grow During the Forecast Period (2026-2036) as Novel Antiseizure Therapies Gain Momentum | DelveInsight
Yahoo Finance ·
- Stoke Therapeutics (STOK) Slips 2.57% to $25.04, Holding Mid-Range of Recent Trading Band - Zero Gamma Level
www.siam.in ·
- Stoke Therapeutics (STOK) Projected to Announce Earnings on Thursday
MarketBeat ·
- Stoke Therapeutics (Nasdaq:STOK) - Stock Analysis
Simply Wall Street ·
- Stoke Therapeutics Stock Price Forecast. Should You Buy STOK?
StockInvest.us ·
- Stoke Therapeutics, Inc. Estimates – NASDAQ:STOK
TradingView ·
- Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2026 Business and Financial Updates
Yahoo Finance ·
- Form 144 STOKE THERAPEUTICS For: 21 October By Investing.com
Investing.com Nigeria ·
- A former affiliate plans to exercise options without cash and sell Stoke Therapeutics (STOK) shares.
Stock Titan ·
- Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Yahoo Finance ·
- Stoke Therapeutics Presents Data Supporting the Disease-Modifying Potential of STK-002 in Autosomal Dominant Optic Atrophy (ADOA) at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting
Yahoo Finance ·
- FDA Alignment on Zorevunersen Endpoints Could Be A Game Changer For Stoke Therapeutics (STOK)
Yahoo Finance ·
Stoke Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $184.4M | $36.6M | $8.8M | $12.4M |
| Net income | -$6.9M | -$89.0M | -$104.7M | -$101.1M |
| Diluted EPS | $-0.12 | $-1.65 | $-2.38 | $-2.60 |
| Total assets (year end) | $418.4M | $271.6M | $228.3M | $256.1M |
| Cash and equivalents (year end) | $84.2M | $128.0M | $191.4M | $113.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Stoke Therapeutics, Inc.
- Ticker
- STOK (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bedford, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1623526
- Former names
- ASOthera Pharmaceuticals, Inc.
Frequently asked questions
What exchange is Stoke Therapeutics, Inc. listed on?
Stoke Therapeutics, Inc. trades on the Nasdaq under the ticker symbol STOK.
What industry is Stoke Therapeutics, Inc. in?
Stoke Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Stoke Therapeutics, Inc. headquartered?
Stoke Therapeutics, Inc.'s business address on file with the SEC is in Bedford, MA.
When does Stoke Therapeutics, Inc.'s fiscal year end?
Stoke Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Stoke Therapeutics, Inc. report?
Stoke Therapeutics, Inc. reported $184.4M in revenue for calendar year 2025, according to its SEC filings.